{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:14:36Z","timestamp":1794694476103,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871595"],"award-info":[{"award-number":["81871595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372533"],"award-info":[{"award-number":["82372533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871595"],"award-info":[{"award-number":["81871595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372533"],"award-info":[{"award-number":["82372533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871595"],"award-info":[{"award-number":["81871595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22MC1940300"],"award-info":[{"award-number":["22MC1940300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22MC1940300"],"award-info":[{"award-number":["22MC1940300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22MC1940300"],"award-info":[{"award-number":["22MC1940300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Giant congenital melanocytic nevus (GCMN) is a RAS\/RAF mutation-driven syndrome characterized by extensive melanocytic lesions, posing psychological challenges and a lifelong risk of malignancy. Existing treatments like surgical resection and laser therapy fail to fully remove lesions, and MAPK inhibitors show limited efficacy. This study identified a predominant population of senescent cells and a minority of proliferative cells in GCMN, necessitating dual-targeted strategies. We found that the anti-apoptotic protein BCL2 is expressed in both senescent and proliferative cells from GCMN patients with various gene mutations. Coexpression of P16 and BCL2 indicated a phenotype of growth arrest and cell survival. BCL2 inhibitors (BCL2i) showed significant cytotoxicity to GCMN cells in vitro. Hypopigmentation and GCMN cell clearance were observed in patient-derived xenograft models and in <jats:italic>Nras<\/jats:italic>\n            <jats:sup>Q61K<\/jats:sup>-mutated and <jats:italic>Braf<\/jats:italic>\n            <jats:sup>V600E<\/jats:sup>-mutated transgenic models following BCL2i treatment. Histology of regressed GCMN indicated extensive immune cell infiltration, suggesting immune involvement. Single-cell sequencing and immunostaining revealed that activated neutrophils formed extracellular traps, synergizing with BCL2i to treat GCMN. Neutrophil depletion and immunosuppression reduce treatment efficacy, highlighting the crucial role of the immune response post-BCL2i treatment. Long-term follow-up showed no recurrence, with neutrophils and T cells residing in the dermis, indicating memory immune reactions. These findings present a promising therapeutic strategy and underscore the translational potential of BCL2i in treating GCMN.<\/jats:p>","DOI":"10.1038\/s41392-025-02247-2","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T23:01:50Z","timestamp":1747350110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction"],"prefix":"10.1038","volume":"10","author":[{"given":"Boxuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huailiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-9199","authenticated-orcid":false,"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-618X","authenticated-orcid":false,"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2247_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2133.1981.tb00954.x","volume":"104","author":"EE Castilla","year":"1981","unstructured":"Castilla, E. E., da Gra\u00e7a Dutra, M. & Orioli-Parreiras, I. M. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br. J. Dermatol 104, 307\u2013315 (1981).","journal-title":"Br. J. Dermatol"},{"key":"2247_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0025-7125(16)30966-X","volume":"70","author":"AR Rhodes","year":"1986","unstructured":"Rhodes, A. R. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. Med. Clin. North Am. 70, 3\u201337 (1986).","journal-title":"Med. Clin. North Am."},{"key":"2247_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/bjd.15301","volume":"176","author":"VA Kinsler","year":"2017","unstructured":"Kinsler, V. A. et al. Melanoma in congenital melanocytic naevi. Br. J. Dermatol 176, 1131\u20131143 (2017).","journal-title":"Br. J. Dermatol"},{"key":"2247_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2133.2008.08849.x","volume":"160","author":"VA Kinsler","year":"2009","unstructured":"Kinsler, V. A., Birley, J. & Atherton, D. J. Great Ormond Street Hospital for Children Registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes. Br. J. Dermatol. 160, 143\u2013150 (2009).","journal-title":"Br. J. Dermatol."},{"key":"2247_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jaad.2005.02.024","volume":"52","author":"BJ Bett","year":"2005","unstructured":"Bett, B. J. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J. Am. Acad. Dermatol. 52, 793\u2013797 (2005).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2247_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2133.2005.06316.x","volume":"152","author":"EK Hale","year":"2005","unstructured":"Hale, E. K. et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi-results from the NYU-LCMN registry. Br. J. Dermatol. 152, 512\u2013517 (2005).","journal-title":"Br. J. Dermatol."},{"key":"2247_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaad.2005.10.040","volume":"54","author":"BJ Bett","year":"2006","unstructured":"Bett, B. J. Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons. J. Am. Acad. Dermatol. 54, 767\u2013777 (2006).","journal-title":"J. Am. Acad. Dermatol"},{"key":"2247_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/jdv.16131","volume":"34","author":"K Neuhaus","year":"2020","unstructured":"Neuhaus, K., Landolt, M. A., Theiler, M., Schiestl, C. & Masnari, O. Skin-related quality of life in children and adolescents with congenital melanocytic naevi - an analysis of self- and parent reports. J. Eur. Acad. Dermatol. Venereol. 34, 1105\u20131111 (2020).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2247_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/jpepsy\/jsz017","volume":"44","author":"O Masnari","year":"2019","unstructured":"Masnari, O. et al. Predictors of health-related quality of life and psychological adjustment in children and adolescents with congenital melanocytic nevi: analysis of parent reports. J. Pediatr. Psychol. 44, 714\u2013725 (2019).","journal-title":"J. Pediatr. Psychol."},{"key":"2247_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/01.prs.0000436852.32527.8a","volume":"133","author":"E Arad","year":"2014","unstructured":"Arad, E. & Zuker, R. M. The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications. Plast. Reconstr. Surg. 133, 367\u2013376 (2014).","journal-title":"Plast. Reconstr. Surg."},{"key":"2247_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/bjd.16094","volume":"178","author":"CAM Eggen","year":"2018","unstructured":"Eggen, C. A. M. et al. Laser treatment of congenital melanocytic naevi: a systematic review. Br. J. Dermatol. 178, 369\u2013383 (2018).","journal-title":"Br. J. Dermatol."},{"key":"2247_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/bjd.18106","volume":"182","author":"S Polubothu","year":"2020","unstructured":"Polubothu, S. et al. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi. Br. J. Dermatol. 182, 434\u2013443 (2020).","journal-title":"Br. J. Dermatol."},{"key":"2247_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jid.2023.06.213","volume":"144","author":"SB Martin","year":"2024","unstructured":"Martin, S. B. et al. Mosaic BRAF fusions are a recurrent cause of congenital melanocytic nevi targetable by MAPK pathway inhibition. J. Invest Dermatol 144, 593\u2013600.e597 (2024).","journal-title":"J. Invest Dermatol"},{"key":"2247_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/neuonc\/nov184","volume":"18","author":"D Basu","year":"2016","unstructured":"Basu, D. et al. Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway. Neuro Oncol. 18, 528\u2013537 (2016).","journal-title":"Neuro Oncol."},{"key":"2247_CR15","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jid.2019.03.1156","volume":"139","author":"T Rouill\u00e9","year":"2019","unstructured":"Rouill\u00e9, T. et al. Local inhibition of MEK\/Akt prevents cellular growth in human congenital melanocytic nevi. J. Invest Dermatol 139, 2004\u20132015.e2013 (2019).","journal-title":"J. Invest Dermatol"},{"key":"2247_CR16","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/jid.2015.114","volume":"135","author":"JS Pawlikowski","year":"2015","unstructured":"Pawlikowski, J. S. et al. Acute inhibition of MEK suppresses congenital melanocytic nevus syndrome in a murine model driven by activated NRAS and Wnt signaling. J. Invest Dermatol 135, 2093\u20132101 (2015).","journal-title":"J. Invest Dermatol"},{"key":"2247_CR17","doi-asserted-by":"crossref","unstructured":"Choi, Y. S. et al. Topical therapy for regression and melanoma prevention of congenital giant nevi. Cell 185, 2071-2085 (2022).","DOI":"10.1016\/j.cell.2022.04.025"},{"key":"2247_CR18","doi-asserted-by":"publisher","first-page":"e20182469","DOI":"10.1542\/peds.2018-2469","volume":"143","author":"A Mir","year":"2019","unstructured":"Mir, A. et al. Giant congenital melanocytic nevus treated with trametinib. Pediatrics 143, e20182469 (2019).","journal-title":"Pediatrics"},{"key":"2247_CR19","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bjd.21851","volume":"187","author":"V Molho-Pessach","year":"2022","unstructured":"Molho-Pessach, V. et al. Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib. Br. J. Dermatol 187, 1052\u20131054 (2022).","journal-title":"Br. J. Dermatol"},{"key":"2247_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2133.2008.08901.x","volume":"160","author":"VA Kinsler","year":"2009","unstructured":"Kinsler, V. A., Birley, J. & Atherton, D. J. Great ormond street hospital for children registry for congenital melanocytic naevi: prospective study 1988-2007. Part 2-evaluation of treatments. Br. J. Dermatol 160, 387\u2013392 (2009).","journal-title":"Br. J. Dermatol"},{"key":"2247_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593\u2013602 (1997).","journal-title":"Cell"},{"key":"2247_CR22","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-05-4006","volume":"66","author":"M Braig","year":"2006","unstructured":"Braig, M. & Schmitt, C. A. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 66, 2881\u20132884 (2006).","journal-title":"Cancer Res"},{"key":"2247_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1600-0560.2007.00912.x","volume":"35","author":"C Stefanaki","year":"2008","unstructured":"Stefanaki, C. et al. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas. J. Cutan. Pathol. 35, 799\u2013808 (2008).","journal-title":"J. Cutan. Pathol."},{"key":"2247_CR24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/sj.onc.1203466","volume":"19","author":"M Kataoka","year":"2000","unstructured":"Kataoka, M. et al. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells. Oncogene 19, 1589\u20131595 (2000).","journal-title":"Oncogene"},{"key":"2247_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer - role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619\u2013636 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2247_CR26","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","volume":"1","author":"NS Gasek","year":"2021","unstructured":"Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Strategies for targeting senescent cells in human disease. Nat. Aging 1, 870\u2013879 (2021).","journal-title":"Nat. Aging"},{"key":"2247_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2247_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland, J. L. & Tchkonia, T. Cellular senescence: a translational perspective. EBioMedicine 21, 21\u201328 (2017).","journal-title":"EBioMedicine"},{"key":"2247_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bjd.12323","volume":"169","author":"VA Kinsler","year":"2013","unstructured":"Kinsler, V. A. et al. Immunohistochemical and ultrastructural features of congenital melanocytic naevus cells support a stem-cell phenotype. Br. J. Dermatol. 169, 374\u2013383 (2013).","journal-title":"Br. J. Dermatol."},{"key":"2247_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/pcmr.12645","volume":"31","author":"VA Kinsler","year":"2018","unstructured":"Kinsler, V. A. & Larue, L. The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation. Pigment Cell Melanoma Res 31, 95\u2013109 (2018).","journal-title":"Pigment Cell Melanoma Res"},{"key":"2247_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","volume":"16","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi, A., Fairbrother, W. J., Leverson, J. D. & Souers, A. J. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat. Rev. Drug Discov. 16, 273\u2013284 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2247_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.tips.2020.09.004","volume":"41","author":"C Cerella","year":"2020","unstructured":"Cerella, C., Dicato, M. & Diederich, M. BH3 Mimetics in AML Therapy: Death and Beyond?. Trends Pharm. Sci. 41, 793\u2013814 (2020).","journal-title":"Trends Pharm. Sci."},{"key":"2247_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","volume":"29","author":"PJ Thompson","year":"2019","unstructured":"Thompson, P. J. et al. Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab. 29, 1045\u20131060.e1010 (2019).","journal-title":"Cell Metab."},{"key":"2247_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"2247_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/01.dad.0000175532.27368.3f","volume":"27","author":"S Krengel","year":"2005","unstructured":"Krengel, S. Nevogenesis-new thoughts regarding a classical problem. Am. J. Dermatopathol. 27, 456\u2013465 (2005).","journal-title":"Am. J. Dermatopathol."},{"key":"2247_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo, C. D. et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N. Engl. J. Med. 383, 617\u2013629 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2247_CR37","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1056\/NEJMoa2213093","volume":"388","author":"B Eichhorst","year":"2023","unstructured":"Eichhorst, B. et al. First-line venetoclax combinations in chronic lymphocytic leukemia. N. Engl. J. Med 388, 1739\u20131754 (2023).","journal-title":"N. Engl. J. Med"},{"key":"2247_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1158\/0008-5472.CAN-07-1580","volume":"68","author":"A Belkhiri","year":"2008","unstructured":"Belkhiri, A., Dar, A. A., Zaika, A., Kelley, M. & El-Rifai, W. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res 68, 395\u2013403 (2008).","journal-title":"Cancer Res"},{"key":"2247_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med 22, 146\u2013153 (2016).","journal-title":"Nat. Med"},{"key":"2247_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-021-00491-3","volume":"7","author":"D Azzouz","year":"2021","unstructured":"Azzouz, D., Khan, M. A. & Palaniyar, N. ROS induces NETosis by oxidizing DNA and initiating DNA repair. Cell Death Discov. 7, 113 (2021).","journal-title":"Cell Death Discov."},{"key":"2247_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-024-01933-x","volume":"9","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Neutrophil extracellular traps in homeostasis and disease. Signal Transduct. Target Ther. 9, 235 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2247_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2247_CR43","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","volume":"185","author":"R Pan","year":"2022","unstructured":"Pan, R., Ryan, J., Pan, D., Wucherpfennig, K. W. & Letai, A. Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. Cell 185, 1521\u20131538.e1518 (2022).","journal-title":"Cell"},{"key":"2247_CR44","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","volume":"189","author":"MJ Kaplan","year":"2012","unstructured":"Kaplan, M. J. & Radic, M. Neutrophil extracellular traps: double-edged swords of innate immunity. J. Immunol. 189, 2689\u20132695 (2012).","journal-title":"J. Immunol."},{"key":"2247_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.trecan.2019.10.013","volume":"5","author":"T Keeley","year":"2019","unstructured":"Keeley, T., Costanzo-Garvey, D. L. & Cook, L. M. Unmasking the many faces of tumor-associated neutrophils and macrophages: considerations for targeting innate immune cells in cancer. Trends Cancer 5, 789\u2013798 (2019).","journal-title":"Trends Cancer"},{"key":"2247_CR46","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","volume":"186","author":"J Gungabeesoon","year":"2023","unstructured":"Gungabeesoon, J. et al. A neutrophil response linked to tumor control in immunotherapy. Cell 186, 1448\u20131464.e1420 (2023).","journal-title":"Cell"},{"key":"2247_CR47","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","volume":"186","author":"D Hirschhorn","year":"2023","unstructured":"Hirschhorn, D. et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell 186, 1432\u20131447.e1417 (2023).","journal-title":"Cell"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02247-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02247-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02247-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T23:01:51Z","timestamp":1747350111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02247-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2247"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02247-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kang Zhang is one of the Editors-in-Chief of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}